Skip to main content

Want a detailed portfolio tracker?

Charles River Laboratories International (CRL) Total Debt (2009 - 2026)

Charles River Laboratories International (CRL) total debt from Dec 26, 2009 to Mar 28, 2026. The current Charles River Laboratories International (CRL) total debt is $4.74B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Charles River Laboratories International (CRL) Total Debt CAGR table

PeriodCAGR
1 Year TTM+26.22%
3 Years TTM+14.55%
5 Years TTM+9.18%
10 Years TTM+15.46%
All Time TTM+14.07%

Annual Total Debt change of Charles River Laboratories International (CRL)

YearTotal DebtChange
2025$3.92B
-2.39%
2024$4.02B
-11.37%
2023$4.54B
-0.94%
2022$4.58B
+3.32%
2021$4.43B
+32.42%
2020$3.35B
+10.60%
2019$3.03B
+20.21%
2018$2.52B
+34.93%
2017$1.87B
+0.42%
2016$1.86B
+42.60%
2015$1.30B
+11.72%
2014$1.17B
+20.47%
2013$968M
-1.53%
2012$983M
-4.64%
2011$1.03B
-1.31%
2010$1.04B
+25.82%
2009$830M
N/A

Comparison Charles River Laboratories International (CRL) total debt with competitors

Charles River Laboratories International (CRL) total debt is $4.74B.

TickerNameTotal DebtUpside
ADVBAdvanced Biomed Inc$1.44M-99.97%
NDRAENDRA Life Sciences Inc$1.65M-99.97%
MBAICheckCap Ltd$1.83M-99.96%
CHEKCheck-Cap Ltd$1.83M-99.96%
APDNApplied Dna Sciences Inc$2.95M-99.94%
MYNZMainz Biomed N.V.$3.13M-99.93%
BIAFBioAffinity Technologies Inc$4.28M-99.91%
ISPCiSpecimen Inc$6.44M-99.86%
PRPOPrecipio Inc$6.64M-99.86%
XWELXWELL Inc$14.91M-99.69%
PREPrenetics Global Ltd - Class A$29.01M-99.39%
XGNExagen Inc$37.52M-99.21%
IMDXInsight Molecular Diagnostics Inc$51.12M-98.92%
FONRFonar Corp$54.77M-98.85%
PRPHProPhase Labs Inc$58.84M-98.76%
PSNLPersonalis Inc$70.63M-98.51%
BDSXBiodesix Inc$85.50M-98.20%
CSTLCastle Biosciences Inc$86.39M-98.18%
VCYTVeracyte Inc$91.99M-98.06%
CDNACaredx Inc$97.53M-97.94%
FLGTFulgent Genetics Inc$112.22M-97.63%
MDXHMDxHealth SA$160.05M-96.62%
BLLNBilliontoone Inc - Class A$195.11M-95.89%
TWSTTwist Bioscience Corp$221.12M-95.34%
WGSGeneDx Holdings Corp - Class A$252.18M-94.68%
ADPTAdaptive Biotechnologies Corp$281.70M-94.06%
GRALGRAIL Inc$302.79M-93.61%
BNRBurning Rock Biotech Ltd$304.48M-93.58%
MYGNMyriad Genetics Inc$336.30M-92.91%
NEONeogenomics Inc$523.27M-88.97%
NOTVInotiv Inc$625.32M-86.81%
OPKOpko Health Inc$652.19M-86.25%
NTRANatera Inc$840.38M-82.28%
MEDPMedpace Holdings Inc$1.53B-67.71%
IDXXIdexx Laboratories Inc$1.83B-61.42%
GHGuardant Health Inc$2.10B-55.79%
RDNTRadnet Inc$2.53B-46.59%
SHCSotera Health Company$2.61B-44.89%
EXASExact Sciences Corp$3.46B-27.04%
MTDMettler-Toledo International Inc$3.71B-21.75%
RVTYRevvity Inc$4.81B+1.52%
AAgilent Technologies Inc$5.91B+24.53%
ICLRIcon Plc$7.08B+49.23%
WATWaters Corp$9.24B+94.83%
LHLaboratory Corp Of America Holdings$10.34B+118.09%
IQVIQVIA Holdings Inc$23.33B+391.90%